Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
- CI for Neogynon 21
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Consumerinfo for Neogynon® 21:
Schering (Schweiz) AG
Complete consumer info
Print
Galenic Form / Therapeutic Group
Effects
Amendments
Contra Indication
Precautions
Pregnancy
Usage
Unwanted effects
General advice
Composition.
Packages
Pre Whosaler
Registration owner
Last update of information
Zusammensetzung
1 Dragee enthält 0,25 mg Levonorgestrel und 0,05 mg Ethinylestradiol sowie Hilfsstoffe.
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
